Osamu Tetsu, MD, PhD

Osamu Tetsu, MD, PhD

Assistant Professor, Department of Otolaryngology - Head and Neck Surgery, UCSF


Phone: (415) 514-0870 (voice)
Box 1330, UCSF
San Francisco, CA 94143-1330

View on UCSF Profiles

Cancer Center Membership

Associate Member » Non-aligned


Chiba University, School of Medicine, M.D., 1989, Medicine
Chiba University, Graduate School of Medicine, Ph.D., 1997, Surgery and Immunology
Chiba University Hospital, Department of Surgery, Residency, 1990-1997, General Surgery
University of California, San Francisco, Postdoc, 1997-2002, Cancer Biology

Professional Experience

  • 1990-1997
    Resident, Department of Surgery, Chiba University Hospital
  • 1997-1999
    Visiting Postdoctoral Fellow, Dr. Frank McCormick Lab, Cancer Research Institute, University of California, San Francisco
  • 1999-2002
    Assistant Research Biochemist, Dr. Frank McCormick Lab, Cancer Research Institute, University of California, San Francisco
  • 2002-2005
    Assistant Adjunct Professor, Cancer Research Institute and Department of Surgery, University of California, San Francisco
  • 2005-2007
    Assistant Adjunct Professor, Department of Pathology, University of California, San Francisco
  • 2007- 2008
    Assistant Adjunct Professor, Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco
  • 2008-present
    Assistant Professor In-Residence, Department of Otolaryngology - Head and Neck Surgery, University of California, San Francisco

Honors & Awards

  • 1990
    Chiba University Hospital, 6th Isono Prize (1st place) for the Best Resident's Presentation
  • 1993-1997
    The Japan Scholarship Foundation, Graduate School Student Fellowship
  • 2000
    The Uehara Memorial Foundation, Research Fellowship Award
  • 2003
    American Cancer Society, Institutional Individual Research Award
  • 2004
    UCSF Research-Evaluation and Allocation Committee (REAC), New Junior Faculty Award
  • 2004
    Chiba University School of Medicine Alumni Association, Outstanding Academic Achievement Award
  • 2004
    The Concern Foundation, Young Investigator Award
  • 2005
    The V Foundation for Cancer Research, V Scholar Award
  • 2009-2010
    UC Cancer Research Coordinating Committee Award

Selected Publications

  1. Phuchareon J, McCormick F, Eisele DW, Tetsu O. EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function. Proc Natl Acad Sci U S A. 2015 Jul 21; 112(29):E3855-63.
    View on PubMed
  2. You B, Yang YL, Xu Z, Dai Y, Liu S, Mao JH, Tetsu O, Li H, Jablons DM, You L. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells. Oncotarget. 2015 Feb 28; 6(6):4357-68.
    View on PubMed
  3. Phuchareon J, Overdevest JB, McCormick F, Eisele DW, van Zante A, Tetsu O. Fatty Acid binding protein 7 is a molecular marker in adenoid cystic carcinoma of the salivary glands: implications for clinical significance. Transl Oncol. 2014 Dec; 7(6):780-7.
    View on PubMed
  4. Phuchareon J, van Zante A, Overdevest JB, McCormick F, Eisele DW, Tetsu O. c-Kit Expression is Rate-Limiting for Stem Cell Factor-Mediated Disease Progression in Adenoid Cystic Carcinoma of the Salivary Glands. Transl Oncol. 2014 Oct; 7(5):537-45.
    View on PubMed
  5. Heaton CM, Durr ML, Tetsu O, van Zante A, Wang SJ. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma. Laryngoscope. 2014 Jul; 124(7):E267-73.
    View on PubMed
  6. Ikeda Y, Oda K, Hiraike-Wada O, Koso T, Miyasaka A, Kashiyama T, Tanikawa M, Sone K, Nagasaka K, Maeda D, Kawana K, Nakagawa S, Fukayama M, Tetsu O, Fujii T, Yano T, Kozuma S. Cyclin D1 harboring the T286I mutation promotes oncogenic activation in endometrial cancer. Oncol Rep. 2013 Aug; 30(2):584-8.
    View on PubMed
  7. Tetsu O, Phuchareon J, Chou A, Cox DP, Eisele DW, Jordan RC. Mutations in the c-Kit gene disrupt mitogen-activated protein kinase signaling during tumor development in adenoid cystic carcinoma of the salivary glands. Neoplasia. 2010 Sep; 12(9):708-17.
    View on PubMed
  8. Phuchareon J, Ohta Y, Woo JM, Eisele DW, Tetsu O. Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2. PLoS One. 2009; 4(6):e6040.
    View on PubMed
  9. Senawong T, Phuchareon J, Ohara O, McCormick F, Rauen KA, Tetsu O. Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options. Hum Mol Genet. 2008 Feb 1; 17(3):419-30.
    View on PubMed
  10. Okabe H, Lee SH, Phuchareon J, Albertson DG, McCormick F, Tetsu O. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation. PLoS One. 2006; 1:e128.
    View on PubMed
  11. Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, McCormick F, Rauen KA. Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science. 2006 Mar 3; 311(5765):1287-90.
    View on PubMed
  12. Rodriguez-Viciana P, Tetsu O, Oda K, Okada J, Rauen K, McCormick F. Cancer targets in the Ras pathway. Cold Spring Harb Symp Quant Biol. 2005; 70:461-7.
    View on PubMed
  13. Tetsu O, McCormick F. Proliferation of cancer cells despite CDK2 inhibition. Cancer Cell. 2003 Mar; 3(3):233-45.
    View on PubMed
  14. Wakita K, McCormick F, Tetsu O. Method for screening ecdysone-inducible stable cell lines. Biotechniques. 2001 Aug; 31(2):414-8.
    View on PubMed
  15. Wakita K, Tetsu O, McCormick F. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics. Cancer Res. 2001 Feb 1; 61(3):854-8.
    View on PubMed
  16. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999 Apr 1; 398(6726):422-6.
    View on PubMed
  17. Tetsu O, Ishihara H, Kanno R, Kamiyasu M, Inoue H, Tokuhisa T, Taniguchi M, Kanno M. mel-18 negatively regulates cell cycle progression upon B cell antigen receptor stimulation through a cascade leading to c-myc/cdc25. Immunity. 1998 Oct; 9(4):439-48.
    View on PubMed
  18. Hasegawa M, Tetsu O, Kanno R, Inoue H, Ishihara H, Kamiyasu M, Taniguchi M, Kanno M. Mammalian Polycomb group genes are categorized as a new type of early response gene induced by B-cell receptor cross-linking. Mol Immunol. 1998 Jun; 35(9):559-63.
    View on PubMed
  19. Kenmochi T, Asano T, Nakagori T, Kaneko K, Nakajima K, Tetsu O, Jingu K, Iwashita C, Kainuma O, Tokoro Y, Sugamoto Y, Sakamoto K, Hatakeyama E, Yamada K, Isono K. Successful gene transfer into murine pancreatic islets using polyamine transfection reagents. Transplant Proc. 1998 Mar; 30(2):470-2.
    View on PubMed
  20. Akasaka T, Tsuji K, Kawahira H, Kanno M, Harigaya K, Hu L, Ebihara Y, Nakahata T, Tetsu O, Taniguchi M, Koseki H. The role of mel-18, a mammalian Polycomb group gene, during IL-7-dependent proliferation of lymphocyte precursors. Immunity. 1997 Jul; 7(1):135-46.
    View on PubMed

Go to UCSF Profiles, powered by CTSI